Clinical trial
Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia A Double Blind, Placebo Controlled, Study in Diabetic and Non-diabetic Patients
NCT00539266 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia A Double Blind, Placebo Controlled, Study in Diabetic and Non-diabetic Patients
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- October 31, 2007
- Completion date
- October 31, 2012
- Enrollment
- 108 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.